IFRX
IFRX
NASDAQ · Biotechnology

Inflarx Nv

$0.89
+0.07 (+8.42%)
As of Feb 8, 2:17 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 9.23M 9.01M 7.68M
Net Income -678,125 -522,642 -466,092
EPS
Profit Margin -7.4% -5.8% -6.1%
Rev Growth +6.0% +24.9% +0.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 6.26M 5.90M 6.22M
Total Equity 27.81M 26.71M 29.49M
D/E Ratio 0.23 0.22 0.21
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -963,511 -904,753 -762,039
Free Cash Flow -508,030 -465,093 -442,494